Article info
Commercial predictive testing: the desirability of one overseeing body
Citation
Commercial predictive testing: the desirability of one overseeing body
Publication history
- First published August 1, 2000.
Online issue publication
August 01, 2000
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2000 by the Journal of Medical Ethics
Other content recommended for you
- Understanding of and attitudes to genetic testing for inherited retinal disease: a patient perspective
- Let the consumer decide? The regulation of commercial genetic testing
- The complexities of predictive genetic testing
- Quality standards and samples in genetic testing
- Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)
- An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation
- Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK
- Exceptional know how? Possible pitfalls of routinising genetic services
- Genetic testing in motor neurone disease